ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
비스포스포네이트 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.5%로 성장할 전망이며, 70억 7,000만 달러로 성장이 예측됩니다. 예측 기간 동안의 성장은 뼈 건강 조사에 대한 투자 증가, 합리적인 가격의 골다공증 치료에 대한 수요 증가, 노인 건강 관리의 중요성 증가, 신흥 시장에서 비스포스포네이트 사용 확대, 디지털 건강 캠페인에 의한 인지도 증가 등으로 인한 것으로 예측됩니다. 이 기간에 예상되는 주요 동향으로는 약물 전달 시스템의 혁신, 생체이용률을 향상시킨 첨단 제형, 병용 요법의 개발, 환자 어드레싱 기술의 진보, 개인화 치료 접근법의 진전 등이 있습니다.
골다공증의 유병률 증가는 향후 수년간 비스포스포네이트 시장의 성장을 이끌 것으로 예측됩니다. 골다공증은 뼈가 약해지고 골절하기 쉬워지는 병리입니다. 골다공증은 노화와 함께 골밀도가 저하되기 때문에 세계적으로 고령화가 진행되고 있는 것 외에 생활습관이나 적절한 예방법이 확립되어 있지 않은 것이 주요 원인이 되고 있습니다. 비스포스포네이트는 골다공증 치료에 효과적이며 뼈 분해를 지연시켜 뼈를 강화하고 골절 위험을 감소시킵니다. 예를 들어, 2024년 8월, 뼈의 건강 조사와 광고에 초점을 맞춘 조직인 Healthy Bones Australia는 2023년에는 골다공증과 골감소증과 관련된 골절이 추정 19만 3,482건으로 평가되었고, 2033년에는 34% 증가한 23만 7,632건이 될 것으로 예상합니다. 따라서 골다공증의 이환율 증가는 비스포스포네이트 시장의 성장을 가속하는 중요한 요소입니다.
조사와 임상 검사 증가는 향후 수년간 비스포스포네이트 시장의 성장을 가속할 것으로 예측됩니다. 임상 검사란 새로운 치료법, 의약품, 의료기기의 안전성, 유효성, 잠재적인 부작용을 평가하는 인간을 대상으로 한 조사연구입니다. 이러한 증가는, 진화하는 헬스케어 요구에 대응해, 환자의 전귀를 향상시키기 위한 혁신적인 치료법에 대한 수요의 고조가 큰 요인이 되고 있습니다. 비스포스포네이트의 맥락에서 임상 연구는 골다공증이나 골 전이와 같은 상태의 관리에서 유효성, 안전성, 장기적 영향을 조사함으로써 뼈의 건강 치료를 진보시키는데 중요한 역할을 하고 있습니다. 예를 들면, 2023년 11월, 영국을 거점으로 하는 단체인 영국 제약 공업 협회(ABPI)는, 영국에서 산업 주도의 임상 검사가 4.3% 증가했으며, 2021년의 394 검사에서 2022년에는 411 검사로 증가했다고 보고했습니다. 이처럼 조사와 임상검사에 대한 관심이 높아지는 것은 비스포스포네이트 시장 확대에 크게 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 비스포스포네이트 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 비스포스포네이트 시장 : 성장률 분석
세계의 비스포스포네이트 시장 실적 : 규모 및 성장(2019-2024년)
세계의 비스포스포네이트 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 비스포스포네이트 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 비스포스포네이트 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
알렌드로네이트
이반도로네이트
리세드로네이트
졸레드론산
세계의 비스포스포네이트 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내
피하
골내
근육내
세계의 비스포스포네이트 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
기타
세계의 비스포스포네이트 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
골다공증
패젯병
골전이
기타
세계의 비스포스포네이트 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
재택 케어
의약품 소매
세계의 비스포스포네이트 시장 : 알렌드로네이트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구정
주별 배합
비타민 D와의 조합
제네릭 알렌드로네이트
세계의 비스포스포네이트 시장 : 이반도로네이트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구정
월별 경구 투여 제제
정맥 주사
제네릭 이반도로네이트
세계의 비스포스포네이트 시장 : 리세드로네이트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
즉방정
지연방출정
주별 및 월별 투여
칼슘과의 조합
세계의 비스포스포네이트 시장 : 졸레드론산별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정맥내 주입
연간 용량
종양학에서의 사용
골다공증의 사용
제네릭 졸레드론산
제7장 지역별 및 국가별 분석
세계의 비스포스포네이트 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 비스포스포네이트 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
비스포스포네이트 시장 : 경쟁 구도
비스포스포네이트 시장 : 기업 프로파일
Pfizer Inc.
Roche Holding AG
Merck & Co. Inc.
AbbVie Inc.
Bayer AG
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
Eli Lilly and Company
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Organon & Co.
Sun Pharmaceutical Industries Ltd.
Apotex Inc.
Aurobindo Pharma Ltd.
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Alkem Laboratories
Natco Pharma Ltd.
Strides Pharma Science Limited
Radius Health Inc.
Warner Chilcott
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
비스포스포네이트 시장(2029년) : 새로운 기회를 제공하는 국가
비스포스포네이트 시장(2029년) : 새로운 기회를 제공하는 부문
비스포스포네이트 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Bisphosphonates are a group of drugs that help prevent bone loss by inhibiting the activity of osteoclasts, making them a primary therapy for osteoporosis and other bone-weakening conditions. They are frequently prescribed to lower the risk of fractures in individuals with low bone density, Paget's disease, or bone metastases due to cancer. These medications aid in strengthening bones, increasing bone mineral density, and reducing fracture risk, especially in postmenopausal women and older adults.
The major types of bisphosphonates include alendronate, ibandronate, risedronate, and zoledronic acid. Alendronate is specifically used to treat and prevent bone-related disorders such as osteoporosis and Paget's disease. These drugs can be administered through various routes, including oral, intravenous, subcutaneous, intraosseous, and intramuscular. They are available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. Primary applications include treating osteoporosis, Paget's disease, and bone metastases, with end users ranging from hospitals and clinics to homecare settings and pharmaceutical retailers.
The bisphosphonates market research report is one of a series of new reports from The Business Research Company that provides bisphosphonates market statistics, including bisphosphonates industry global market size, regional shares, competitors with a bisphosphonates market share, detailed bisphosphonates market segments, market trends and opportunities, and any further data you may need to thrive in the bisphosphonates industry. This bisphosphonates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bisphosphonates market size has grown strongly in recent years. It will grow from $5.39 billion in 2024 to $5.70 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the increasing incidence of multiple myeloma, a rise in glucocorticoid-induced osteoporosis cases, the prevalence of sedentary lifestyles, greater availability of generic bisphosphonates, and the growing use of these medications in treating metastatic bone disease.
The bisphosphonates market size is expected to see strong growth in the next few years. It will grow to $7.07 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The projected growth in the forecast period can be attributed to increased investment in bone health research, rising demand for affordable osteoporosis treatments, a growing emphasis on elderly healthcare, expanding use of bisphosphonates in emerging markets, and heightened awareness driven by digital health campaigns. Key trends expected during this period include innovations in drug delivery systems, advanced formulations with enhanced bioavailability, the development of combination therapies, advancements in patient adherence technologies, and progress in personalized treatment approaches.
The rising prevalence of osteoporosis is expected to drive the growth of the bisphosphonates market in the coming years. Osteoporosis is a medical condition marked by weakened bones that are more susceptible to fractures. Its growing prevalence is mainly attributed to the aging global population, as bone density naturally declines with age, along with contributing lifestyle factors and a lack of adequate preventive measures. Bisphosphonates are effective in treating osteoporosis by slowing bone degradation, thereby strengthening bones and lowering fracture risk. For example, in August 2024, Healthy Bones Australia, an organization focused on bone health research and advocacy, reported that in 2023, there were an estimated 193,482 fractures linked to osteoporosis and osteopenia, with projections indicating a 34% increase to 237,632 fractures by 2033. Thus, the rising incidence of osteoporosis is a key factor fueling the growth of the bisphosphonates market.
The rise in research and clinical trials is expected to drive the growth of the bisphosphonates market in the coming years. Clinical trials are research studies involving human participants that assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. This increase is largely fueled by the growing demand for innovative therapies to meet evolving healthcare needs and enhance patient outcomes. In the context of bisphosphonates, clinical research plays a critical role in advancing bone health treatments by examining their efficacy, safety, and long-term impact in managing conditions like osteoporosis and bone metastases. For example, in November 2023, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported a 4.3% increase in industry-initiated clinical trials in the UK, rising from 394 trials in 2021 to 411 in 2022. Thus, the growing focus on research and clinical trials is contributing significantly to the expansion of the bisphosphonates market.
In May 2023, Abiogen Pharma S.p.A., an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for an undisclosed amount. This acquisition is intended to strategically enhance and diversify Abiogen's rare disease portfolio by incorporating EffRx's innovative therapies for musculoskeletal and rare conditions. It also supports Abiogen's goal of expanding its international footprint and strengthening its capabilities in the development and commercialization of specialized treatments worldwide. EffRx Pharmaceuticals SA is a Switzerland-based specialty pharmaceutical company that produces and markets bisphosphonates for the treatment of osteoporosis.
Major players in the bisphosphonates market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Organon & Co., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Natco Pharma Ltd., Strides Pharma Science Limited, Radius Health Inc., Warner Chilcott.
North America was the largest region in the bisphosphonates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bisphosphonates report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the bisphosphonates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bisphosphonates market consists of sales of oral tablets, bisphosphonate capsules, bisphosphonate injections, oral solutions, and intravenous (IV) infusions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bisphosphonates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bisphosphonates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bisphosphonates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bisphosphonates market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
2) By Route Of Administration: Oral; Intravenous; Subcutaneous; Intraosseous; Intramuscular
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
4) By Application: Osteoporosis; Paget's Disease; Bone Metastasis; Other Application
5) By End-User: Hospitals; Clinics; Homecare Settings; Pharmaceutical Retail
Subsegments:
1) By Alendronate: Oral Tablets; Once-Weekly Formulation; Combination With Vitamin D; Generic Alendronate
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bisphosphonates Market Characteristics
3. Bisphosphonates Market Trends And Strategies
4. Bisphosphonates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Bisphosphonates Growth Analysis And Strategic Analysis Framework
5.1. Global Bisphosphonates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bisphosphonates Market Growth Rate Analysis
5.4. Global Bisphosphonates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bisphosphonates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bisphosphonates Total Addressable Market (TAM)
6. Bisphosphonates Market Segmentation
6.1. Global Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alendronate
Ibandronate
Risedronate
Zoledronic Acid
6.2. Global Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
Intraosseous
Intramuscular
6.3. Global Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Bisphosphonates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Osteoporosis
Paget's Disease
Bone Metastasis
Other Application
6.5. Global Bisphosphonates Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare Settings
Pharmaceutical Retail
6.6. Global Bisphosphonates Market, Sub-Segmentation Of Alendronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Once-Weekly Formulation
Combination With Vitamin D
Generic Alendronate
6.7. Global Bisphosphonates Market, Sub-Segmentation Of Ibandronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Monthly Oral Formulation
Intravenous Injection
Generic Ibandronate
6.8. Global Bisphosphonates Market, Sub-Segmentation Of Risedronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Tablets
Delayed-Release Tablets
Weekly And Monthly Dosing
Combination With Calcium
6.9. Global Bisphosphonates Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Infusion
Annual Dosing
Oncology Use
Osteoporosis Use
Generic Zoledronic Acid
7. Bisphosphonates Market Regional And Country Analysis
7.1. Global Bisphosphonates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bisphosphonates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bisphosphonates Market
8.1. Asia-Pacific Bisphosphonates Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bisphosphonates Market
9.1. China Bisphosphonates Market Overview
9.2. China Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bisphosphonates Market
10.1. India Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bisphosphonates Market
11.1. Japan Bisphosphonates Market Overview
11.2. Japan Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bisphosphonates Market
12.1. Australia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bisphosphonates Market
13.1. Indonesia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bisphosphonates Market
14.1. South Korea Bisphosphonates Market Overview
14.2. South Korea Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bisphosphonates Market
15.1. Western Europe Bisphosphonates Market Overview
15.2. Western Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bisphosphonates Market
16.1. UK Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bisphosphonates Market
17.1. Germany Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bisphosphonates Market
18.1. France Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bisphosphonates Market
19.1. Italy Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bisphosphonates Market
20.1. Spain Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bisphosphonates Market
21.1. Eastern Europe Bisphosphonates Market Overview
21.2. Eastern Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bisphosphonates Market
22.1. Russia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bisphosphonates Market
23.1. North America Bisphosphonates Market Overview
23.2. North America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bisphosphonates Market
24.1. USA Bisphosphonates Market Overview
24.2. USA Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bisphosphonates Market
25.1. Canada Bisphosphonates Market Overview
25.2. Canada Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bisphosphonates Market
26.1. South America Bisphosphonates Market Overview
26.2. South America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bisphosphonates Market
27.1. Brazil Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bisphosphonates Market
28.1. Middle East Bisphosphonates Market Overview
28.2. Middle East Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bisphosphonates Market
29.1. Africa Bisphosphonates Market Overview
29.2. Africa Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bisphosphonates Market Competitive Landscape And Company Profiles
